Dergiler / International Journal of Traditional and Complementary Medicine Research / 2026 / Volume: 7 Issue: 1

Association Between Systemic Ozone Therapy and Subjective Sleep Quality: A Prospective Pilot Clinical Study

Aksanur Gökçe(Amasya University, Department of Family Medicine)0000-0001-8547-6523
Sayfa
—
Yayın Tarihi
2026-04-27
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These findings are exploratory and preliminary.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: It is known that poor sleep quality increases the likelihood of developing a wide range of chronic diseases.
📊
Temel Bulgular & Veri:Furthermore, it is also known to lead to increased healthcare costs and reduced workforce productivity.
💡
Sonuç & Katkı:These findings are exploratory and preliminary.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Systemic ozone therapy · sleep quality · complementary and integrative medicine

Abstract

Aim: It is known that poor sleep quality increases the likelihood of developing a wide range of chronic diseases. Furthermore, it is also known to lead to increased healthcare costs and reduced workforce productivity. The aim of this study is twofold: firstly, to investigate the effect of systemic ozone therapy on subjective sleep quality; secondly, to evaluate its safety profile. Material and Methods: This prospective, single-centre study comprised 51 patients (31 females, 20 males; mean age = 51.05 ± 11.85 years) receiving routine systemic ozone therapy—administered rectally—at an outpatient clinic specialising in Traditional and Complementary Medicine (TCM). The Pittsburgh Sleep Quality Index (PSQI) was utilised to assess sleep quality prior to and following a standardised 8-week ozone therapy protocol comprising 10 sessions. Results: PSQI scores were associated with significant improvements after treatment (mean change −2.72 ± 3.21; p < 0.001) and approached thresholds considered clinically significant in previous sleep research. GLMM analyses revealed significant main effects of time, age, gender, education, income, and comorbid health conditions on PSQI outcomes (all p < 0.05). No serious adverse events were observed throughout the study period. Conclusion: The current study demonstrated that systemic ozone therapy was associated with a significant improvement in subjective sleep quality, exhibiting a positive safety profile, albeit with a small pilot group and short follow-up period. These findings suggest that ozone therapy may be a promising complementary approach for managing sleep disorders, particularly in older adults and individuals with comorbid conditions. These findings are exploratory and preliminary.

🔖

Bu Makaleye Atıf Yap

Gökçe, A., Topçu, E., Yakşi, N. (2026). Association Between Systemic Ozone Therapy and Subjective Sleep Quality: A Prospective Pilot Clinical Study. International Journal of Traditional and Complementary Medicine Research, Volume: 7 Issue: 1. https://doi.org/10.53811/ijtcmr.1821844

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (29)

  1. Garbarino S, Lanteri P, Sannita WG, Bragazzi NL, Scoditti E. Circadian rhythms, sleep, immunity, and fragilty in the elderly: the model of the susceptibility to infections. Front Neurol. 2020;11:558417. doi:10.3389/fneur.2020.558417.
  2. Smagula SF, Stone KL, Redlin S, Ancoli-Israel S, Barrett-Connor E, Lane, NE, et. al. Actigraphy- and polysomnography-measured sleep disturbances, inflammation, and mortality among older men. Psychosom Med. 2016;78:686-96. doi:10.1097/PSY.0000000000000312.
  3. Shen W, Liu N, Ji Z, Fang H, Liu F, Zhang, Wet al. Combining ozonated autohemotherapy with pharmacological therapy for comorbid insomnia and myofascial pain syndrome: a prospective randomized controlled study. Pain Res Manag. 2022;2022:3562191. doi:10.1155/2022/3562191.
  4. Galiè M, Covi V, Tabaracci G, Malatesta M. The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int J Mol Sci. 2019;20(16):4009. doi:10.3390/ijms20164009.
  5. Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011;2(1):66-70. doi:10.4103/0976-9668.82319.
  6. Zitser J, Allen IE, Falgàs N, Le MM, Neylan TC, Kramer, JH. Et al. Pittsburgh Sleep Quality Index (PSQI) responses and sleep parameters in healthy older adults. PloS One. 2022;17(6):e0270095. doi:10.1371/journal.pone.0270095.
  7. Grandner MA, Jackson NJ, Pak VM, Gehrman PR. Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res. 2012;21(4):427-33. doi:10.1111/j.1365-2869.2011.00990.x.
  8. Araghi MH, Jagielski A, Neira I, Brown A, Higgs S, Thomas GN, et. al. The complex associations among sleep quality, anxiety-depression, and quality of life in patients with extreme obesity. Sleep. 2013;36(12):1859-65. doi:10.5665/sleep.3216.
  9. Li Y, Feng X, Ren H, Huang H, Wang Y, Yu S. Low-dose ozone therapy improves sleep quality in patients with insomnia and coronary heart disease by elevating serum BDNF and GABA. Bull Exp Biol Med. 2021;170(4):493-8. doi:10.1007/s10517-021-05095-6.
  10. Uşen A, Özcan DS, Ağirman M, Güner H, Kocyigit BF. Short- and Medium-Term effects of ajör Ozone therapy on disease parameters in fibromyalgia syndrome: a retrospective study. Rheumatol Int. 2025;45(4):72. doi:10.1007/s00296-025-05827-1.
  11. Sucuoğlu H, Soydaş N. Efficacy of ozone therapy as an add-on treatment in fibromyalgia: a randomized double-blind placebo-controlled study. J Back Musculoskelet Rehabil. 2023;36(2):357-66. doi:10.3233/BMR-210368.
  12. Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Gas Res. 2009;29(4):646-82. doi:10.1002/med.20150.
  13. Hu S, Chen Y, Chen Y, Wang C. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry. 2021;12:714057. doi:10.3389/fpsyt.2021.714057.
  14. Patel NP, Grandner MA, Xie D, Branas CC, Gooneratne N. "Sleep disparity" in the population: poor sleep quality is strongly associated with poverty and ethnicity. BMC Public Health. 2010;10:475. doi:10.1186/1471-2458-10-475.
  15. Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin. 2018;13(3):443-56. doi:10.1016/j.jsmc.2018.04.011.
  16. Billings ME, Cohen RT, Baldwin CM, Johnson DA, Palen BN, Parthasarathy S et.al. Disparities in sleep health and potential intervention models: a focused review. Chest. 2021;159(3):1232-40. doi:10.1016/j.chest.2020.09.249.
  17. Runge N, Ahmed I, Saueressig T, Perea J, Labie C, Mairesse O, et. al. The bidirectional relationship between sleep problems and chronic musculoskeletal pain: a systematic review with meta-analysis. Pain. 2024;165(11):2455-67. doi:10.1097/j.pain.0000000000003279.
  18. Mishima K, Okawa M, Shimizu T, Hishikawa Y. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab. 2001;86(1):129-34. doi:10.1210/jcem.86.1.7097.
  19. Youngstedt SD, Kripke DF, Elliott JA, Klauber MR. Circadian abnormalities in older adults. J Pineal Res. 2001;31(3):264-72. doi:10.1034/j.1600-079x.2001.310311.x.
  20. Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7(3):212-219. doi:10.4103/2045-9912.215752.
  21. Irwin MR, Opp MR. Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology. 2017;42(1):129-55. doi:10.1038/npp.2016.148.
  22. Davinelli S, Medoro A, Savino R, Scapagnini G. Sleep and oxidative stress: current perspectives on the role of NRF2. Cell Mol Neurobiol. 2024;44(1):52. doi:10.1007/s10571-024-01487-0.
  23. Feng V, Tumati S, Wang R, Bawa KK, Gallagher D, Herrmann N, et.al. The relationship between oxidative stress and subjective sleep quality in people with coronary artery disease. Brain Sci. 2022;12(8):1070. doi:10.3390/brainsci12081070.
  24. de Sire A, Marotta N, Ferrillo M, Agostini F, Sconza C, Lippi L, et. al. Oxygen-ozone therapy for reducing pro-inflammatory cytokines serum levels in musculoskeletal and temporomandibular disorders: a comprehensive review. Int J Mol Sci. 2022;23(5):2528. doi:10.3390/ijms23052528.
  25. Stewart SA, The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66 Suppl 2:9-13.
  26. Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev. 2000;4(6):551-81. doi:10.1053/smrv.2000.0126.
  27. Givler D, Givler A, Luther PM, Wenger DM, Ahmadzadeh S, Shekoohi S, et.al. Chronic administration of melatonin: physiological and clinical considerations. Neurol Int. 2023;15(1):518-33. doi:10.3390/neurolint15010031.
  28. Hillman D, Mitchell S, Streatfeild J, Burns C, Bruck D, Pezzullo L. The economic cost of inadequate sleep. Sleep. 2018;41(8):zsy083. doi:10.1093/sleep/zsy083.
  29. Glick DR, Abariga SA, Thomas I, Shipper AG, Gunia BC, Grandner MA, et. al. Economic impact of insufficient and disturbed sleep in the workplace. Pharmacoeconomics. 2023;41(7):771-85. doi:10.1007/s40273-023-01249-8.